FR2663223B1
(fr)
*
|
1990-06-14 |
1994-12-02 |
Af Aplicaciones Far Lab |
Forme galenique parenterale.
|
DE4041563A1
(de)
*
|
1990-12-22 |
1992-06-25 |
Sanol Arznei Schwarz Gmbh |
Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US6514533B1
(en)
|
1992-06-11 |
2003-02-04 |
Alkermas Controlled Therapeutics, Inc. |
Device for the sustained release of aggregation-stabilized, biologically active agent
|
JP3717925B2
(ja)
*
|
1992-09-29 |
2005-11-16 |
ネクター セラピューティクス |
副甲状腺ホルモンの活性フラグメントの肺導入
|
US7425543B2
(en)
*
|
1992-11-16 |
2008-09-16 |
The Corporation Of Mercer University |
Microencapsulated materials and method of making same
|
US5997904A
(en)
*
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
ATE264671T1
(de)
*
|
1993-02-22 |
2004-05-15 |
American Bioscience Inc |
Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
CA2150251C
(en)
*
|
1993-04-28 |
2005-02-22 |
Arnold Titus Philip Skrabanja |
Lyospheres comprising gonadotropin
|
CA2163860A1
(en)
*
|
1993-06-30 |
1995-01-12 |
Chung C. Hsu |
Method for preparing liposomes
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
FR2720645B1
(fr)
*
|
1994-06-03 |
1996-08-02 |
Oreal |
Procédé d'obtention d'une matière première sous forme de granulés, matière première sous forme de granulés et son utilisation dans le domaine cosmétique, capillaire, vétérinaire ou pharmaceutique.
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US5922253A
(en)
*
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
AU710347B2
(en)
*
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
JP2893167B2
(ja)
*
|
1995-09-29 |
1999-05-17 |
農林水産省東北農業試験場長 |
コンテナ収集用運搬車
|
IL120202A
(en)
*
|
1996-03-07 |
2001-03-19 |
Akzo Nobel Nv |
Container with freeze-dried vaccine components
|
US6148536A
(en)
*
|
1996-06-10 |
2000-11-21 |
Nippon Telegraph And Telephone Corporation |
Two-fluid nozzle and device employing the same nozzle for freezing and drying liquid containing biological substances
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
AU750567B2
(en)
*
|
1997-09-29 |
2002-07-25 |
Novartis Ag |
Stabilized preparations for use in nebulizers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
CA2324568A1
(en)
|
1998-03-20 |
1999-09-30 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation of physiologically active polypeptide and production thereof
|
FR2776520B1
(fr)
*
|
1998-03-25 |
2000-05-05 |
Sod Conseils Rech Applic |
Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
EP1121413A1
(de)
*
|
1998-10-15 |
2001-08-08 |
The Procter & Gamble Company |
Verfahren zur herstellung eines nanoporösen körnigen materials und eines waschmittels
|
JP2002540850A
(ja)
|
1999-04-05 |
2002-12-03 |
ファーマシューティカル ディスカバリー コーポレイション |
微粉形成のための方法
|
EP1658840A1
(de)
*
|
1999-04-05 |
2006-05-24 |
Mannkind Corporation |
Verfahren zur Bildung von feinem Pulver
|
US6444223B1
(en)
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
SE9903236D0
(sv)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
WO2001021187A1
(fr)
|
1999-09-17 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Procede de production d'une poudre proteique
|
US6284283B1
(en)
*
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
GB0004827D0
(en)
*
|
2000-02-29 |
2000-04-19 |
Quadrant Holdings Cambridge |
Compositions
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
CA2382133C
(en)
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
JP2004523479A
(ja)
*
|
2000-10-18 |
2004-08-05 |
マサチューセッツ インスティテュート オブ テクノロジー |
多糖の肺送達に関する方法および産物
|
GB0102075D0
(en)
|
2001-01-26 |
2001-03-14 |
Astrazeneca Ab |
Process
|
EP1357900A2
(de)
*
|
2001-01-30 |
2003-11-05 |
Board of Regents, The University of Texas System |
Herstellungsprozess von nanopartikeln und mikropartikeln durch sprühgefrierung in flüssigkeit
|
ES2173047B1
(es)
*
|
2001-03-21 |
2004-01-01 |
Aplicaciones Farmacodinamicas |
Procedimiento para la obtencion de las diferentes fracciones de guayaba atomizada y su uso para el tratamiento de la diabetes mellitus tipo ii
|
WO2002101412A2
(en)
|
2001-06-08 |
2002-12-19 |
Powderject Vaccines, Inc. |
Spray freeze-dried compositions
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
MXPA04004730A
(es)
*
|
2001-11-19 |
2004-07-30 |
Becton Dickinson Co |
Composiciones farmaceuticas en forma particulada.
|
US7368102B2
(en)
|
2001-12-19 |
2008-05-06 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
FR2834636B1
(fr)
*
|
2002-01-15 |
2006-02-24 |
El Hassane Larhrib |
Procede de fabrication de particules micro-poreuses creuses, notamment destinees a etre inhalees
|
AU2003220125B2
(en)
|
2002-03-20 |
2006-06-15 |
Mannkind Corporation |
Inhalation apparatus
|
WO2004073827A1
(en)
*
|
2003-02-21 |
2004-09-02 |
The University Of Bath |
Process for the production of particles
|
JP2007508240A
(ja)
*
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
SI2409707T1
(sl)
|
2004-04-15 |
2015-07-31 |
Alkermes Pharma Ireland Limited |
Naprava s podaljšanim sproščanjem na osnovi polimerov
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
BRPI0514263B8
(pt)
|
2004-08-20 |
2021-05-25 |
Mannkind Corp |
método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida
|
HUE026134T2
(en)
|
2004-08-23 |
2016-05-30 |
Mannkind Corp |
Microparticles containing diketopiperazine salts for drug delivery
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP1868574B1
(de)
*
|
2005-04-13 |
2010-01-06 |
Abbott GmbH & Co. KG |
Verfahren zur schonenden herstellung hochfeiner partikelsuspensionen und hochfeiner partikel sowie deren verwendung
|
WO2006116546A1
(en)
*
|
2005-04-27 |
2006-11-02 |
Baxter International Inc. |
Surface-modified microparticles and methods of forming and using the same
|
ES2640282T3
(es)
|
2005-09-14 |
2017-11-02 |
Mannkind Corporation |
Método de formulación de fármacos basado en el aumento de la afinidad de superficies de micropartículas cristalinas para agentes activos
|
EP1976486A1
(de)
*
|
2006-01-27 |
2008-10-08 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
Verfahren zur herstellung von porösen mikroteilchen
|
CN104383546B
(zh)
|
2006-02-22 |
2021-03-02 |
曼金德公司 |
用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
US20080075777A1
(en)
*
|
2006-07-31 |
2008-03-27 |
Kennedy Michael T |
Apparatus and methods for preparing solid particles
|
CN105168146A
(zh)
*
|
2006-08-04 |
2015-12-23 |
巴克斯特国际公司 |
预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
|
DK2359808T3
(da)
|
2006-08-09 |
2013-08-05 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelaggregater
|
JP2010505882A
(ja)
*
|
2006-10-06 |
2010-02-25 |
バクスター・インターナショナル・インコーポレイテッド |
表面改質微粒子を含むマイクロエンカプセルならびに、その形成および使用の方法
|
EP1915987A1
(de)
*
|
2006-10-27 |
2008-04-30 |
MediGene AG |
Sprühgefriertrocknungsverfahren zur Herstellung von Pellets enthaltend eine Percolationstrocknung
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
WO2009132265A2
(en)
*
|
2008-04-25 |
2009-10-29 |
The University Of North Carolina At Chapel Hill |
Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates
|
IL279542B2
(en)
|
2008-06-13 |
2023-10-01 |
Mannkind Corp |
Dry powder inhaler and drug delivery system
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CA2728523C
(en)
|
2008-06-20 |
2020-03-10 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
US20110150926A1
(en)
*
|
2008-08-01 |
2011-06-23 |
Mohammed Alsharifi |
Influenza vaccines
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8323685B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8721583B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US20100111845A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Compositions and methods for therapeutic delivery with frozen particles
|
US8545856B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8545855B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8793075B2
(en)
|
2008-10-31 |
2014-07-29 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US20100111857A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Boyden Edward S |
Compositions and methods for surface abrasion with frozen particles
|
US9060934B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9050070B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8603495B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US8731840B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8858912B2
(en)
*
|
2008-10-31 |
2014-10-14 |
The Invention Science Fund I, Llc |
Frozen compositions and methods for piercing a substrate
|
US9050317B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9072688B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060926B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8545857B2
(en)
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8603494B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8414356B2
(en)
*
|
2008-10-31 |
2013-04-09 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8731842B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US8788211B2
(en)
*
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US8731841B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8762067B2
(en)
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
US8409376B2
(en)
|
2008-10-31 |
2013-04-02 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8725420B2
(en)
*
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8551505B2
(en)
*
|
2008-10-31 |
2013-10-08 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US20100178038A1
(en)
*
|
2009-01-12 |
2010-07-15 |
Mediatek Inc. |
Video player
|
US20100189800A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Peter Markland |
Continous double emulsion process for making microparticles
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
EP2405963B1
(de)
|
2009-03-11 |
2013-11-06 |
MannKind Corporation |
Gerät, system und verfahren zur messung von widerstand in einem inhaliergerät
|
MY157166A
(en)
|
2009-06-12 |
2016-05-13 |
Mankind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
ES2650667T3
(es)
|
2009-09-28 |
2018-01-19 |
Intarcia Therapeutics, Inc |
Rápido establecimiento y/o terminación de la administración sustancial de fármaco en estado estacionario
|
US9016147B2
(en)
|
2009-11-03 |
2015-04-28 |
Mannkind Corporation |
Apparatus and method for simulating inhalation efforts
|
BR112012033060A2
(pt)
|
2010-06-21 |
2018-02-27 |
Mannkind Corp |
métodos de sistema de liberação de fármaco em pó seco
|
US20130203675A1
(en)
|
2010-09-16 |
2013-08-08 |
Joseph M. DeSimone |
Asymmetric biofunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
|
US20140079732A1
(en)
|
2011-01-27 |
2014-03-20 |
Gamma Vaccines Pty Limited |
Combination vaccines
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CN103945859A
(zh)
|
2011-10-24 |
2014-07-23 |
曼金德公司 |
用于治疗疼痛的方法和组合物
|
MX354163B
(es)
|
2012-07-12 |
2018-02-15 |
Mannkind Corp |
Sistemas y métodos de suministro de fármaco en polvo seco.
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
EP2938664A4
(de)
*
|
2012-12-28 |
2016-08-24 |
Nathan T Starbard |
Poröse polymerpartikel und verfahren zur herstellung und verwendung davon
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
KR102321339B1
(ko)
|
2013-07-18 |
2021-11-02 |
맨카인드 코포레이션 |
열-안정성 건조 분말 약제학적 조성물 및 방법
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
JP6628299B2
(ja)
*
|
2014-08-25 |
2020-01-08 |
国立研究開発法人物質・材料研究機構 |
粒子形成方法及び粒子
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
CN107427569B
(zh)
|
2015-03-26 |
2022-12-30 |
Gpn疫苗有限公司 |
链球菌疫苗
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
US10835580B2
(en)
|
2017-01-03 |
2020-11-17 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
CN114160040B
(zh)
*
|
2021-12-09 |
2022-07-12 |
广州风行乳业股份有限公司 |
一种液氮深冷制粒设备
|